Dysbiosis of human gut microbiome in young-onset colorectal cancer.
Yongzhi YangLutao DuDebing ShiCheng KongJianqiang LiuGuang LiuXinxiang LiYanlei MaPublished in: Nature communications (2021)
The incidence of sporadic young-onset colorectal cancer (yCRC) is increasing. A significant knowledge gap exists in the gut microbiota and its diagnostic value for yCRC patients. Through 16S rRNA gene sequencing, 728 samples are collected to identify microbial markers, and an independent cohort of 310 samples is used to validate the results. Furthermore, species-level and functional analysis are performed by metagenome sequencing using 200 samples. Gut microbial diversity is increased in yCRC. Flavonifractor plautii is an important bacterial species in yCRC, while genus Streptococcus contains the key phylotype in the old-onset colorectal cancer. Functional analysis reveals that yCRC has unique characteristics of bacterial metabolism characterized by the dominance of DNA binding and RNA-dependent DNA biosynthetic process. The random forest classifier model achieves a powerful classification potential. This study highlights the potential of the gut microbiota biomarkers as a promising non-invasive tool for the accurate detection and distinction of individuals with yCRC.
Keyphrases
- dna binding
- microbial community
- end stage renal disease
- endothelial cells
- single cell
- ejection fraction
- newly diagnosed
- transcription factor
- deep learning
- risk factors
- prognostic factors
- human health
- genome wide
- single molecule
- candida albicans
- risk assessment
- patient reported outcomes
- escherichia coli
- staphylococcus aureus
- nucleic acid
- loop mediated isothermal amplification
- biofilm formation
- early onset
- label free